| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director
2 companies
Levy Guy is a Director at BioAtla, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 5 sells.
Estimated insider holdings value: $22.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc. Common Stock | 10% Owner | Buy | 500,000 | $20.00 | $10,000,000.00 | +42.4% | - | - | |
| Aug 24, 2021 | BCAB Bioatla, Inc. | Director | Sell | 546,709 | $39.65 | $21,677,011.85 | -19.7% | -38.5% | -78.2% | |
| Jun 17, 2021 | BCAB Bioatla, Inc. | Director | Sell | 400,000 | $39.16 | $15,664,000.00 | -18.8% | -4.0% | -93.2% | |
| Dec 18, 2020 | BCAB Bioatla, Inc. | Director | Buy | 1,388,890 | $18.00 | $25,000,020.00 | New | - | - |